Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors
Risks
Default risk
Data is available to registered users only
Volatility
Data is available to registered users only
Selling difficulty
Data is available to registered users only
Stress test
Data is available to registered users only
Country risks
Data is available to registered users only
Other risks
Data is available to registered users only
Sign up to access detailed risk analysis
About
NeonMind Biosciences Inc. operates as an integrated psychedelic drug development and wellness company in Canada. The company provides psychedelic drugs to address public health needs, including obesity, weight management, and mental health. It operates in two divisions, Pharmaceutical and Medical Services. The company offers drug development research services for the potential therapeutic uses of psychedelic compounds, as well as focuses on launching specialty mental health clinics that integrate psychedelic therapeutics into traditional psychotherapy settings. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is based in Oakville, Canada.